|  | 
| MechanismKATP channels activators | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhaseApproved | 
| First Approval Ctry. / Loc.Japan | 
| First Approval Date21 Sep 1983 | 
100 Clinical Results associated with Jiangsu Pingguang Pharmaceutical Co. Ltd.
0  Patents (Medical) associated with Jiangsu Pingguang Pharmaceutical Co. Ltd.
100 Deals associated with Jiangsu Pingguang Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Jiangsu Pingguang Pharmaceutical Co. Ltd.